Transfusion strategies in hematologic and nonhematologic disease

Hematology (United States)

Volumn 2014, Issue 1, 2014, Pages 548-552

  Carson, Jeffrey L ^a   Strair, Roger ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BLOOD TRANSFUSION; CLINICAL TRIAL (TOPIC); HEMATOLOGIC DISEASES; HUMAN; PATHOLOGY; PRACTICE GUIDELINE; RISK FACTOR;

ANEMIA; BLOOD TRANSFUSION; CLINICAL TRIALS AS TOPIC; HEMATOLOGIC DISEASES; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 84937540103     PISSN: 15204391     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2014.1.548     Document Type: Article

References (27)

1. Carson JL, Reynolds RC, Klein HG. Bad bad blood? Crit Care Med. 2008;36(9):2707-2708.
2. Carson JL, Hebert PC. Here we go again- blood transfusion kills patients?: Comment on "Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversityadjusted study sequential analysis". JAMA Intern Med. 2013;173(2):139-141.
3. Pinchon DJ, Stanworth SJ, Doree C, Brunskill S, Norfolk DR. Quality of life and use of red cell transfusion in patients with myelodysplastic syndromes: a systematic review. Am J Hematol. 2009;84(10):671-677.
4. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB∗. Ann Intern Med. 2012;157(1):49-58.
5. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002;42(7):812-818.
6. Wu WC, Schifftner TL, Henderson WG, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA. 2007;297(22):2481-2488.
7. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378(9800):1396-1407.
8. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042.
9. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group [see comments]. N Engl J Med. 1999;340(6): 409-417.
10. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365(26):2453-2462.
11. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11-21.
12. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304(14):1559-1567.
13. Bracey AW, Radovancevic R, Riggs SA, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion. 1999;39(10):1070-1077.
14. Cooper HA, Rao SV, Greenberg MD, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol. 2011;108(8):1108-1111.
15. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J. 2013;165(6):964-971.
16. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group [see comments]. N Engl J Med. 1995;333(4):206-213.
17. Howard J, Malfroy M, Llewelyn C, et al. The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet. 2013;381(9870):930-938.
18. Al-Jaouni SK A-MS, Qari MH, Nawas MA, Al-Mazrooa A. Randomized clinical trial to evaluate the safety of avoiding pre-operative transfusion in sickle cell anaemia. Bahrain Medical Bulletin. 2006;28: 164-167.
19. Tay J, Tinmouth A, Fergusson D, Allan D. Transfusion of red cells in hematopoietic stem cell transplantation (TRIST): study protocol for a randomized controlled trial. Trials. 2011;12:207.
20. Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356(16): 1609-1619.
21. Kirpalani H, Whyte RK, Andersen C, et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149(3):301-307.
22. Bell EF. Transfusion thresholds for preterm infants: how low should we go? J Pediatr. 2006;149(3):287-289.
23. Trey JE, Kushner I. The acute phase response and the hematopoietic system: the role of cytokines. Crit Rev Oncol Hematol. 1995;21(1-3):1-18.
24. Corwin HL, Gettinger A, Fabian TC, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med. 2007;357(10):965-976.
25. Jelkmann I, Jelkmann W. Impact of erythropoietin on intensive care unit patients. Transfus Med Hemother. 2013;40(5):310-318.
26. Carson JL, Carless PA, Hebert PC. Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. JAMA. 2013;309(1): 83-84.
27. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA. 2014;311(13):1317-1326.